Skip to main content
Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · IEX Real-Time Price · USD
40.05
-0.60 (-1.48%)
At close: Jul 26, 2024, 4:00 PM
40.00
-0.05 (-0.12%)
After-hours: Jul 26, 2024, 6:30 PM EDT

Tandem Diabetes Care Revenue

Tandem Diabetes Care had revenue of $191.67M in the quarter ending March 31, 2024, with 13.16% growth. This brings the company's revenue in the last twelve months to $770.01M, down -3.11% year-over-year. In the year 2023, Tandem Diabetes Care had annual revenue of $747.72M, down -6.68%.

Revenue (ttm)
$770.01M
Revenue Growth
-3.11%
P/S Ratio
3.36
Revenue / Employee
$320,837
Employees
2,400
Market Cap
2.59B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023747.72M-53.50M-6.68%
Dec 31, 2022801.22M98.42M14.00%
Dec 31, 2021702.80M203.97M40.89%
Dec 31, 2020498.83M136.53M37.68%
Dec 31, 2019362.31M178.44M97.05%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
agilon health 4.78B
Envista Holdings 2.56B
Progyny 1.11B
PTC Therapeutics 927.56M
MorphoSys AG 264.75M
Kymera Therapeutics 79.41M
Agios Pharmaceuticals 29.40M
SpringWorks Therapeutics 26.45M
Revenue Rankings

TNDM News

More News